FDAFDA · Food and drugs·Recall number D-0594-2024
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Published July 17, 2024 · Recall initiated: July 3, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: reduced efficacy for epinephrine
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- TAILSTORM HEALTH INC
- Distributor
- Nationwide in the USA
- Lot
- Lot Number: 2311003, Expiration Date: 11/13/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.